Laminins are components of all basal laminae (BLs)^1^ throughout the bodies of vertebrates and invertebrates. In mammals they play at least three essential roles. First, they are major structural elements of BLs, forming one of two self-assembling networks (the other is composed of the collagens IV) to which other glycoproteins and proteoglycans of the BL attach (for review see [@B91]; [@B80]). Second, they interact with cell surface components such as dystroglycan to attach cells to the extracellular matrix (for review see [@B38]). Third, they are signaling molecules that interact with cellular receptors such as the integrins to convey morphogenetically important information to the cell\'s interior (for review see [@B15]; [@B57]; [@B89]). For example, laminin promotes myogenesis in skeletal muscle, outgrowth of neurites from central and peripheral neurons, and mesenchymal to epithelial transitions in kidney ([@B26]; [@B48]; [@B66]; [@B82]).

Laminin was initially isolated from tumor cells as a heterotrimer of A, B1, and B2 subunits ([@B14]; [@B81]), later renamed α1, β1, and γ1 ([@B9]). Molecular cloning revealed that the three subunits were encoded by distinct but homologous genes ([@B54]). Subsequently, homologues of the α1 chain (merosin, or α2; [@B20]) and the β1 chain (s-laminin, or β2; [@B41]) were isolated, revealing a previously unsuspected heterogeneity of laminins. Five additional laminin chains have now been identified, all of which clearly belong to the α, β, or γ subfamilies (α3--5, β3, and γ2; [@B47]; [@B70]; [@B2]; [@B67]; [@B30]; [@B60]). All native laminins isolated to date are composed of one α, one β, and one γ chain, and seven distinct heterotrimers have been identified (for review see [@B22]). The existence of multiple chains that oligomerize with a defined stoichiometry provides a means to generate functional diversity within a common structural framework ([@B72]).

Here we focus on the α subfamily of laminin chains. This is the largest subfamily, with five members identified to date in mammals. Interactions of cells with laminin α chains are critical for cell--matrix interactions. For example, at least six distinct integrin heterodimers (α1β1, α2β1, α3β1, α6β1, α7β1, and αvβ3), as well as dystroglycan, heparin, and the adhesion molecule--associated glycoconjugate HNK-1/L2, bind to sites on laminin α chains ([@B65]; [@B29]; [@B35]; [@B79]; [@B57]; [@B56]; Colognato, H., and P.D. Yurchenco. 1996. *Mol. Biol. Cell.* 7(Suppl.):67*a*). Moreover, both dystroglycan and some integrins can distinguish amongst different α chains, suggesting that α chain diversity is functionally significant ([@B57]; [@B63]). In direct support of this notion, mutations in two α chains, α2 and α3, lead to congenital muscular dystrophy and junctional epidermolysis bullosa, respectively ([@B78]; [@B88]; [@B36]; [@B55]). In *Drosophila*, mutation of the only known laminin α chain is embryonically lethal, leading to defects in numerous tissues ([@B37]; [@B90]; [@B28]).

Despite their importance, limited information is available about the distribution of the α chains (see, e.g., [@B24]; [@B72]; [@B86]; [@B84], [@B85]). Moreover, the α1 chain has been studied most intensively in human tissues with a single mAb (4C7; [@B23], 1990) whose specificity for α1 has been questioned ([@B21]). For the recently discovered α4 and α5 chains, no direct evidence has been presented to show that they form heterotrimers, and no data on cellular localization have been reported. Accordingly, we have generated and characterized antibodies to the α4 and α5 chains and used them to identify four novel laminin heterotrimers: laminin-8 (α4β1γ1), laminin-9 (α4β2γ1), laminin-10 (α5β1γ1), and laminin-11 (α5β2γ1). Using a panel of antibodies and cDNA probes, we analyzed the distribution of all five laminin α chains in embryonic and adult mice. We show that the α chains are expressed in overlapping but distinct patterns, with each BL containing at least one of the known α chains. Moreover, we demonstrate that some individual BLs contain different complements of α chains at distinct stages of their development. Finally, we identify a novel isoform of α3 and report the chromosomal locations of all five α chains in mice.

Materials and Methods
=====================

Isolation of cDNAs
------------------

### Laminin α3B.

We performed the reverse transcription--coupled PCR (RT-PCR) using embryonic day (E) 17.5 mouse lung RNA and primers designed to amplify sequences encoding the NH~2~-terminal portion of domain VI of laminin α5. Surprisingly, the reaction generated a novel 209-bp fragment that was similar but not identical to known α chains. We hypothesized that this fragment could be part of a laminin α3B cDNA extending 5′ of that reported by [@B27]. To test this hypothesis, two primers were used in RT-PCR from adult lung RNA to attempt to amplify the potentially intervening cDNA: sense, 5′AGCGGGACCCAGAGGTC3′ (from the novel product); antisense, 5′TGCCTCACAGACAATCTCACC3′ (from near the 5′ end of the sequence in Galliano et al. \[1995\]). RT-PCR conditions were as described ([@B58]), with the addition of Taq Extender PCR Additive (Stratagene Cloning Systems, La Jolla, CA). A 2.2-kb fragment was sequenced with a Taq DyeDeoxy Terminator cycle sequencing kit (Applied Biosystems, Inc., Foster City, CA), and sequence was analyzed on the BLAST server at the National Center for Biotechnology Information ([@B7]). Sequence was obtained from multiple clones to resolve errors introduced by Taq polymerase amplification.

### Laminin α4.

A mouse laminin α4 cDNA fragment was amplified by RT-PCR from E17.5 placenta using degenerate primers based on the human amino acid sequence ([@B67]). The primers, designed to amplify the mouse segment homologous to nucleotides 1,800--2,607, were: sense, 5′TCNATGATGTTYGAYGGNCARTC3′; antisense, 5′CGNCCRCTRCTRAANCCRAARTC3′. The fragment was isolated on a low melting point gel and ligated into the pCRII vector (Invitrogen, San Diego, CA). The DNA and deduced amino acid sequences were determined and have been deposited into GenBank under accession number U88352.

RNA Analyses
------------

RNA was prepared from mouse tissues by acid guanidinium phenol/chloroform extraction ([@B13]). RNase protections were performed as described ([@B59]) using \[^32^P\]UTP-labeled probes and 5 μg (E17.5) or 7.5 μg (adult) of total RNA per hybridization. A probe for elongation factor 1α was included to control for the quality and amount of input RNA. For Northern analysis, a filter containing poly(A)-selected RNA from several adult mouse tissues (Clontech, Palo Alto, CA) was hybridized according to the manufacturer\'s instructions. In situ hybridizations were performed with ^35^S-UTP--labeled probes as described ([@B50]). The laminin α chain probes used for RNase protection assays and in situ hybridizations were as described ([@B50]).

Antibodies
----------

Rat mAbs to mouse laminin α1 (clones 198 and 200; [@B77]) were gifts from Lydia Sorokin (Institute for Experimental Medicine, Erlangen, Germany). A rabbit antiserum to human laminin α2 cross-reactive with the mouse protein ([@B82]) was kindly provided by Peter Yurchenco (Robert Wood Johnson Medical School, Piscataway, NJ). A rabbit antiserum to mouse laminin α3 ([@B1],*b*) was a gift from Daniel Aberdam (INSERM U385, Nice, France). Mouse mAbs to rat laminin chains β1 (C21, C22), β2 (D7, D19, D27), and γ1 (D18) were produced and characterized in our laboratory and have been described previously ([@B71]; [@B41]; [@B72]; [@B33]). A guinea pig antiserum against a recombinant COOHterminal fragment of laminin β2 was produced as described ([@B72]). A rat mAb to laminin γ1 was purchased from Chemicon (Temecula, CA). Second antibodies were purchased as follows: fluorescein- and HRP-conjugated goat anti--rabbit antibodies from Boehringer Mannheim Biochemicals (Indianapolis, IN); fluorescein-conjugated goat anti--rat antibodies from Cappel/Organon Teknika (Durham, NC); Cy3-conjugated goat anti--rabbit antibodies from Jackson ImmunoResearch Laboratories (West Grove, PA); biotinylated goat anti--guinea pig antibodies from Sigma Chemical Co. (St. Louis, MO).

To generate antibodies to the laminin α4 and α5 chains, the laminin α4 cDNA described above, another containing nucleotides 3,670--4,391 (described in [@B50]), and a laminin α5 fragment comprising nucleotides 4,243--4,926 (SacI to EcoRV) were each cloned in frame into the pET 23 vector (Novagen, Madison, WI). Proteins were produced in BL21(DE3) bacteria, and inclusion bodies were isolated according to a protocol supplied by Novagen. Fusion proteins were gel isolated as described ([@B58]) and used to immunize rabbits (Caltag, Healdsburg, CA). For both α4 and α5, two separately immunized rabbits generated antisera that displayed qualitatively similar patterns of reactivity on both sections and immunoblots. The higher titer antiserum to each immunogen was used for the studies reported here.

Immunohistochemistry
--------------------

Mouse tissues were frozen fresh and sectioned at 4--8 μm on a cryostat. Antibodies were diluted in 1% (wt/vol) BSA in PBS and incubated on sections for 1--2 h. After rinsing off unbound primary antibody with PBS, secondary antibodies were applied for 1--2 h. Sections were rinsed again, and then mounted in glycerol-para-phenylenediamine and observed with epifluorescent illumination. Since the laminin α4 antisera only recognized denatured antigen, the following protocol was used when staining with these antibodies: sections were fixed in 2% paraformaldehyde in PBS for 20 min, rinsed in PBS, incubated with 100 mM glycine in PBS for 10 min, incubated in 0.05% SDS in PBS for 30 min at 50°C, and then rinsed in PBS before the antibody was applied. Anti-α5 stained untreated and SDS- denatured sections in qualitatively similar patterns.

Western Blots and Immunoprecipitations
--------------------------------------

For immunoblotting, tissues from rat were used because a greater range of mAbs was available against rat than against mouse laminin β and γ chains (see above). Lungs and kidneys from saline-perfused adult rats were homogenized in ice-cold 40 mM Tris, pH 7.5, 15 mM NaCl, and 2 mM CaCl~2~ (H buffer) containing protease inhibitors (0.1 mM PMSF, 1 mM benzamidine, and 1 μg/ml soybean trypsin inhibitor) using a Polytron. Crude membrane fractions were recovered at 20,000 *g*, washed once with H buffer containing PMSF, resuspended in H buffer containing 10 mM EDTA, 2 mM EGTA, PMSF, and soybean trypsin inhibitor (H+E buffer), and stored at −10°C. To improve immunoblotting sensitivity for BL components, the crude pellet was extracted by brief sonication in H+E buffer with 0.1 M NaCl and 1% Triton X-100, pelleted at 50,000 *g*, and resuspended in H+E buffer. However, data qualitatively similar to those presented in Results were obtained with the crude pellet. Protein content was assayed with bicinchoninic acid reagents (Pierce Chemical Co., Rockford, IL) using BSA as a standard. Purified Engelbreth-Holm-Swarm (EHS) laminin-1 was obtained from Gibco BRL (Gaithersburg, MD).

Samples were solubilized by boiling in SDS gel loading buffer with or without DTT. The proteins were then separated by SDS-PAGE and transferred to nitrocellulose using standard methods. Fusion proteins, reduced native laminins, and nonreduced native laminins were separated on 12%, 7%, and 3.5% polyacrylamide gels, respectively. After blotting, filters were blocked with nonfat dry milk/0.3% Tween-20 in PBS, and then incubated with antibodies overnight. For detecting the fusion proteins, antisera were preadsorbed to an unrelated fusion protein containing the common pET 23 leader and His tag sequences. Bound antibodies were detected with either HRP-conjugated second antibody (for rabbit) or biotinylated second antibody with HRP-conjugated Z-avidin (Zymed Laboratories, South San Francisco, CA) (for guinea pig), and Renaissance chemiluminescent substrate (DuPont/New England Nuclear, Boston, MA).

For immunoprecipitations, laminins were first partially purified from adult rat lung by the protocol of [@B51], modified as follows: crude membranes were prepared as described above, and then extracted repeatedly over 12 h with 50 mM Tris, pH 7.5, 0.15 M NaCl, 10 mM EDTA, and 10 mM EGTA (TBS/EDTA). The pooled extracts were diluted to 90 mM NaCl, adjusted to pH 8.3, and loaded onto a DEAE-- Sepharose CL-4B column (Pharmacia, Uppsala, Sweden). The column was eluted with 1.0 M NaCl, and fractions containing laminin β2 (detected by immunoblotting) were pooled and brought to 50% saturation with ammonium sulfate. Precipitated material was resuspended in TBS/EDTA, brought to 10% glycerol, 0.6 M KCl, and 0.05% Tween-20, and then fractionated on a Sepharose CL-4B column. Fractions containing laminin β2 were pooled and passed through CM--Sepharose CL-6B; the flow-through was resubjected to DEAE--Sepharose chromatography. Protein eluted with 0.5 M NaCl was stored at −70°C with 0.1 mM PMSF. Protein was measured by Bradford assay (Bio Rad Laboratories, Hercules, CA). SDSPAGE of this fraction under reducing conditions displayed a heterogeneous population of proteins \>180 kD, along with the laminin-binding protein entactin (150 kD) as a major constituent.

Laminins were immunoprecipitated essentially by the method of [@B33], modified as follows: laminin samples were incubated with antiβ1 mAbs (a mixture of C21 and C22) or anti-β2 antibodies (a mixture of D7, D19, and D27) in 50 mM Tris, pH 8.0, 100 mM NaCl, 2 mM EDTA, 1% NP-40, and 0.05% sodium deoxycholate (IP buffer). Immune complexes were isolated using protein A--Sepharose 4B (Pharmacia) that was preblocked with 4 mg/ml IgG-free BSA (Sigma Chemical Co.) and washed in IP buffer. Rabbit anti--mouse IgG (Fc) antibodies (Jackson ImmunoResearch Laboratories) were included to bridge mAbs to protein A. Precipitated laminins were dissolved by boiling in SDS-PAGE sample buffer, separated by SDS-PAGE, and then detected by Western blotting as above.

Interspecific Mouse Backcross Mapping
-------------------------------------

Interspecific backcross progeny were generated by mating (C57BL/6J × *Mus spretus*) F1 females and C57BL/6J males as described ([@B16]). DNA isolation, restriction enzyme digestion, agarose gel electrophoresis, and Southern blot transfer and hybridization were performed essentially as described ([@B43]). All blots were prepared with Zetabind nylon membrane (Cuno, Inc., Meriden, CT). Probes, which were specific for each locus, were labeled with \[^32^P\]dCTP using a random primed labeling kit (Amersham Corp., Arlington Heights, IL) or a nick translation labeling kit (Boehringer Mannheim Biochemicals); washing was done to a final stringency of 0.8--1.0 × SSC and 0.1% SDS at 65°C. The probe and restriction fragment length polymorphisms (RFLPs) for *Lama1* have been described previously ([@B62]). The *Lama2* probe, a ∼360-bp fragment of mouse cDNA from domain G, detected fragments of 10.5 kb in C57BL/6J (B) DNA and 5.4 and 4.2 kb in *M. spretus* (S) DNA after digestion with PstI. The *Lama3* probe, a ∼500-bp fragment of mouse cDNA from domains I/II, detected EcoRV fragments of 10.5 kb (B) and ∼23.0 kb (S). A second probe, a genomic clone containing a portion of domain VI of laminin α3B, gave results identical to those obtained with the domain I/II probe. The *Lama4* probe, a ∼800-bp fragment of mouse cDNA from domain G, detected BglII fragments of 4.4 and 1.7 kb (B) and 6.0 kb (S). The *Lama5* probe, a ∼7.5-kb fragment of mouse genomic DNA from domains V and IVb, detected BamHI fragments of 4.2, 3.7, and 3.3 kb (B) and 4.2, 3.3, 2.3, and 1.8 kb (S). The presence or absence of *M. spretus*--specific fragments was followed in backcross mice. A total of 205 N~2~ mice were used to map each *Lama* locus.

Descriptions of most of the probes and RFLPs for the loci used to position the *Lama* loci in the interspecific backcross have been reported. These include: *Gnas*, chromosome 2 ([@B87]); *Myb*, *Fyn*, and *Ros1*, chromosome 10 ([@B44]); *Fert* and *Tik*, chromosome 17 ([@B25]; [@B62]); and *Tpl2*, *Cdh2*, and *Ttr*, chromosome 18 ([@B45], 1994). One locus has not been reported previously for this interspecific backcross: the *Mc3r* probe, a 2.0-kb BamHI/ XhoI fragment of mouse cDNA, was kindly provided by Roger Cone (Vollum Institute, Portland, OR) and detected SphI fragments of 3.5 kb (B) and 5.9 kb (S). Recombination distances were calculated as described ([@B31]) using the computer program SPRETUS MADNESS. Gene order was determined by minimizing the number of recombination events required to explain the allele distribution patterns.

Results and Discussion
======================

The Laminin α Chain Family: Identification of Full-Length α3
------------------------------------------------------------

The α subfamily of laminin chains currently contains five members. Fig. [1](#F1){ref-type="fig"} shows the domain structure of these chains based on the nomenclature of [@B73]. All α chains contain a carboxyl-terminal globular G domain and α-helical domains I and II. The previously described fulllength α1 and α2 chains contain six additional domains (IIIa--VI) that alternate between cysteine-rich stretches containing EGF-like repeats (IIIa, IIIb, and V) and globular regions (IVa, IVb, and VI) ([@B22]). The newest member of the family, α5, is also a full-length chain, but it is larger than α1 or α2, owing to the greater number of EGF-like repeats in domain V and a larger domain IVb ([@B60]). In contrast, laminins α3A and α4 are severely truncated chains that contain only a single cysteine-rich domain (IIIa) downstream of a short aminoterminal domain ([@B70]; [@B27]; [@B42]; [@B68]). Of the vertebrate α chains, α5 may be most like the ancestral α chain, because of its similarity in both domain structure and sequence to the only known invertebrate α chain, *Drosophila* A ([@B60]).

The only laminin gene so far shown to encode more than a single polypeptide is the laminin α3 gene. The two known products, α3A and α3B, differ at their amino termini, resulting from alternative splicing and/or alternative promoter usage. The shorter α3A chain was the first to be identified by both immunological methods ([@B69]) and by cDNA cloning ([@B2]). Subsequently, however, multiple α3 cDNAs were identified in human ([@B70]) and mouse ([@B27]), suggesting the existence of a second, longer isoform called α3B. Sequence analysis ([@B27]) indicated that α3B contains two cysteine-rich (IIIa and IIIb) and two globular (IVa and IV′′) domains in addition to the G and I/II domains, but no domains V or VI. This would make it the sole "mid-sized" α chain. However, we have obtained mouse cDNAs (see Materials and Methods) that extend the previously reported sequence 5′ by ∼2.2 kb (Fig. [2](#F2){ref-type="fig"}). This novel sequence encodes the NH~2~-terminal portion of domain IVb, a complete domain V, and what is likely all but a few amino acids of a domain VI. These domains are most similar in sequence and predicted tertiary structure to the analogous domains of laminin α5. For example, the amino acid sequence of domain VI is 74% identical to that of α5, but only 54 and 51% identical to those of α1 and α2, respectively. A probe from the 5′ end of this sequence recognized ∼10-kb bands on Northern blots of mouse RNA from adult brain, lung, and kidney (data not shown). The proposed α3B structure is shown in Fig. [1](#F1){ref-type="fig"}, indicating its unique NH~2~ terminus and the COOH terminus it shares with α3A.

There is a discrepancy between our sequence and that of [@B27]: a single base near the 5′ end of their reported sequence is absent from our cDNAs (see last line of Fig. [2](#F2){ref-type="fig"}). As a result of this insertion, the methionine residue that [@B27] suggested to initiate translation of α3B and the following amino acid are encoded in a different reading frame than is the extended sequence reported here (Fig. [2](#F2){ref-type="fig"}). Possible explanations for this discrepancy include a polymorphism between mouse strains, alternative splicing of exons that differ by only one base, RNA editing, sequencing error, or cDNA cloning artifact. We cannot exclude any of these possibilities, although we consider the first three unlikely and note that our sequence, derived from multiple cDNAs, generates a single uninterrupted open reading frame (∼9.8 kb) extending through the region of discrepancy. Therefore, we favor the interpretation that there is no mid-sized form of laminin α3, but only the severely truncated α3A and the full-length α3B form reported here. Full-length α3B would thus contain ∼3,300 amino acids and have a molecular mass of ∼360 kD. Thus, the α subfamily of laminin chains currently consists of four long (α1, α2, α3B, and α5) and two short (α3A and α4) proteins.

Differential Expression of Laminin α Chain Genes in Embryos and Adults
----------------------------------------------------------------------

As a first step in assessing the distribution of the laminin α chains, we performed RNase protection analyses on RNA isolated from a set of eight adult tissues plus a late-term (E17.5) placenta (Fig. [3](#F3){ref-type="fig"} *A*). Laminin α1 was readily detectable only in placenta, but long autoradiographic exposures revealed low levels in kidney. Laminin α2 RNA was present at levels above background (yeast RNA lane) in heart, kidney, lung, muscle, and skin. Laminin α3A/B was expressed primarily in lung, skin, and intestine, although very low levels of this RNA were also detectable in kidney. In contrast, laminin α4 RNA was present in all tissues at low (liver) to moderate (lung) levels. Laminin α5 transcripts were also easily detectable in all tissues, although levels were very low in liver. Thus, each laminin α chain is expressed in a distinct pattern. Interestingly, the two most recently discovered laminins, α4 and α5, are the most widely expressed. The α2 and α3 chains show more restricted patterns of expression. In general, α2 levels were highest in tissues with large mesodermally derived components (skeletal and cardiac muscle), whereas α3 levels were highest in organs that are rich in epithelia (skin, intestine, and lung). The notion that α2 and α3 are predominantly mesodermal and epithelial products, respectively, has been proposed ([@B86]; [@B1]). Finally, expression of laminin α1, the initially described α chain, was the most severely restricted of the five.

We next tested RNAs prepared from the same tissues but at a late fetal (E17.5) stage. In general, patterns of expression seen in the fetus were similar to those seen in adults, although levels of expression were generally higher in the fetus (Fig. [3](#F3){ref-type="fig"} *B*). Laminin α1 was again the least widely expressed α chain, although its RNA was readily detected in fetal kidney as well as in placenta. Likewise, laminins α2--5 were expressed at moderate to high levels in a variety of tissues, consistent with patterns seen in adults. Thus, the distinct patterns of laminin α chain expression found in adult tissues are, for the most part, established before birth.

To map α chain expression in younger embryos (E15.5), we used in situ hybridization. Laminin α1 was detected in the kidney and in the meninges of the central nervous system (Fig. [4](#F4){ref-type="fig"} *a*). Laminin α2 was observed primarily in the developing skeletal musculature, in dorsal root ganglia, and in kidney (Fig. [4](#F4){ref-type="fig"} *b*). Laminin α3A/B was strongly expressed in skin, lung, olfactory epithelium, and the superficial layers of the tongue and palate (Fig. [4](#F4){ref-type="fig"} *c*). Laminin α4 was expressed strongly in mesenchymal tissues of the head, in dorsal root ganglia, and in intestine, and was observed diffusely in skeletal and cardiac muscle (Fig. [4](#F4){ref-type="fig"} *d*). Finally, laminin α5 was expressed in a pattern similar to α3, with additional sites of expression in salivary gland, in intestine, and in the most superficial cells of the liver (Fig. [4](#F4){ref-type="fig"} *e*).

When compared with the RNase protection results from E17.5 (Fig. [3](#F3){ref-type="fig"} *B*), it is apparent that the main sites of expression are already established by E15.5: α2 and α4 in muscle, α3 and α5 in skin, and α3--5 in lung. There are, however, a few differences. For example, α2 is barely detectable in heart at E15.5 but is expressed strongly at E17.5; the presence of α4 in heart at E15.5 suggests that there may be a developmental transition in α chain expression in the heart in which α4 is joined by α2. In addition, a particularly interesting pattern of α3--α5 chain expression was observed in the lung, as shown at higher power in Fig. [4](#F4){ref-type="fig"}, *f--h.* α3 and α5 were confined to the epithelial lung buds at this stage, while α4 was expressed only in the surrounding mesenchyme. This complementary pattern of expression suggests that these chains may play distinct roles in lung development: α3 and α5 in branching morphogenesis, and α4 in the organization of the mesenchyme.

Identification of Laminin α4 and α5 Proteins
--------------------------------------------

The α1--3 chains were first identified by biochemical and immunochemical methods ([@B81]; [@B49]; [@B69]; [@B11]; [@B83]). In contrast, α4 and α5 were identified as cDNAs by molecular cloning ([@B67]; [@B42]; [@B60]). Sequence analysis implies that the α4 and α5 cDNAs encode laminin-like proteins, but it is crucial to demonstrate this directly. To this end, we used α4 and α5 cDNAs to produce recombinant proteins in bacteria, and then used the proteins to generate antisera in rabbits. Each antiserum specifically recognized its immunogen on Western blots (Fig. [5](#F5){ref-type="fig"} *A*), and immunoreactivity was removed by incubation with the corresponding fusion protein. Since α3B and α5 sequences are closely related (see above), we also tested anti-α5 on a recombinant fragment from the corresponding domains of α3B. No cross-reaction was detected (data not shown).

To detect laminin α4 and α5 proteins, we prepared extracts of adult lung and kidney; lung was chosen because it expresses both chains at high levels (Fig. [3](#F3){ref-type="fig"} *A*), and kidney was chosen because it was the focus of immunohistochemical studies detailed below. Tissue BL proteins and purified laminin-1 (α1/β1/γ1) were reduced, fractionated by gel electrophoresis, and transferred to nitrocellulose filters, which were then probed with antisera to laminins α4 or α5 or with an antiserum to laminin-1. Results are shown in Fig. [5](#F5){ref-type="fig"} *B.* Anti-α4 recognized an ∼180-kD protein in both lung and kidney (Fig. [5](#F5){ref-type="fig"} *B*, lanes *3* and *8*). Anti-α5 recognized large proteins of ∼380 and ∼350 kD, as well as a smaller protein of ∼210 kD, in both tissues (Fig. [5](#F5){ref-type="fig"} *B*, lanes *4* and *9*). Additional specific anti-α5--reactive bands of high *M* ~r~ (∼450 kD) were observed with longer exposure times in several experiments (Fig. [5](#F5){ref-type="fig"} *B*, lane *5*). Neither anti-α4 nor anti-α5 reacted with the ∼400-kD α1 chain of laminin-1 (Fig. [5](#F5){ref-type="fig"} *B*, lanes *12* and *13*), although this chain was readily detected by a polyclonal antiserum to laminin-1 (lane *10*). Nonimmune rabbit serum was not reactive with any of the laminin chains (Fig. [5](#F5){ref-type="fig"} *B*, lanes *2*, *7*, and *11*). Thus, the laminin α4 and α5 chains are present in adult lung and kidney, and this is consistent with results of RNase protection assays (Fig. [3](#F3){ref-type="fig"} *A*).

The *M* ~r~ of the anti-α4--reactive protein, ∼180 kD, is consistent with the size predicted from the open reading frame of the cDNA (190 kD; [@B42]; [@B68]). Likewise, the ∼450-kD α5 chain is of the expected size for this presumably glycosylated protein. The observation that smaller α5-immunoreactive bands (380, 350, and 210 kD) are more abundant than the 450-kD species indicates that α5 is subject to posttranslational cleavage. Multiple protease inhibitors were used in preparing tissue, and the relative abundance of the bands in the extracts remained constant for several weeks at 4°C. We therefore suspect that this cleavage occurred in situ, as has been reported for laminins α2 and α3 ([@B20]; [@B52]), rather than during isolation.

Cellular Distribution of Laminin α Chains in Adult Tissues
----------------------------------------------------------

The laminin α1--3 chains have been shown to be associated with BLs in a variety of tissues, as have the β and γ chains. Here we asked whether α4 and α5 are components of BLs, and whether their expression overlaps those of the α1--3 chains. In addition, we wanted to know whether all BLs contained at least one α chain, as the finding of an apparently α-free BL might suggest the existence of additional α chains. We began by using our α4 and α5 antisera, along with previously characterized antibodies to α1--3 (see Materials and Methods), to investigate the expression patterns of the laminin α chains in kidney, a tissue that contains numerous heterogeneous yet well-characterized BLs ([@B6]; [@B72]; [@B4]; Abrahamson and St. John, 1993; [@B58]; [@B84]).

Laminin α1 was readily detected in the BLs of a subset of renal tubules (primarily proximal), as shown previously ([@B39]; [@B77]). The α1 chain was absent from glomerular BL but was present in the glomerular mesangium, an amorphous matrix that is one of the few sites in which laminins are present outside of a formed BL (Fig. [6](#F6){ref-type="fig"} *a*). No α1 was detectable in the BLs of arteries, veins, or capillaries. In the peripheral portion of the kidney, laminin α2 was largely restricted to the mesangium, in agreement with previous studies of human kidney (Fig. [6](#F6){ref-type="fig"} *b*; [@B72]; [@B84]). At deeper levels, however, some tubules were weakly α2 positive, particularly in the transitional zone between the cortex and medulla (the corticomedullary junction; Fig. [6](#F6){ref-type="fig"} *b*, *inset*). Laminin α3 was absent from glomeruli, tubules, and vasculature of the renal cortex (data not shown), but it was present in the epithelial BL that lines the papilla (Fig. [6](#F6){ref-type="fig"} *c*). Laminin α4 was absent from all renal, epithelial, and arterial BLs (Fig. [6](#F6){ref-type="fig"} *d*) but was found in many capillaries of the medulla (not shown). Finally, laminin α5 was detected in virtually all BLs, including those of glomeruli, arteries, and all tubules (Fig. [6](#F6){ref-type="fig"} *e*). Thus, all five of the known α chains are present in adult kidney, but each is expressed in a unique pattern.

To extend these studies, we examined two other BL-rich tissues, heart and lung. As in kidney, the laminin α chains were primarily restricted to BLs, and each chain was expressed in a distinct pattern. In the heart, laminins α1 and α3 were undetectable (Fig. [6](#F6){ref-type="fig"}, *f* and *h*). Laminin α2 was abundant in the myocyte BLs (Fig. [6](#F6){ref-type="fig"} *g*), as reported previously ([@B49]; [@B64]), while laminin α4, as in the kidney, was restricted to capillaries (Fig. [6](#F6){ref-type="fig"} *i*). Laminin α5 was present in arterioles and capillaries and was also found at low levels in many myocyte BLs (Fig. [6](#F6){ref-type="fig"} *j*). In lung, laminin α3 was present in alveolar BL (Fig. [6](#F6){ref-type="fig"} *m*), consistent with a recent report by Virtanen et al. (1996). The α5 chain was colocalized with α3 in most alveolar BLs (Fig. [6](#F6){ref-type="fig"} *o*), while laminin α4 was detected in a large subset of these BLs (Fig. [6](#F6){ref-type="fig"} *n*). The identity of the α4positive BLs remains to be determined. Interestingly, however, in developing lung, protein localization mirrors the RNA localization documented above: α3 and α5 are concentrated in the epithelial lung buds, with α4 in the mesenchyme (data not shown; Miner, J.H., manuscript in preparation). Laminins α1 and α2 were not detectable in lung (Fig. [6](#F6){ref-type="fig"}, *k* and *l*).

Several conclusions can be drawn from these results. First, all laminin α chains are confined to the extracellular matrix and, with the exception of the glomerular mesangium, to BLs. Cytoplasmic deposits of laminins were not detected, nor were any laminin α chains present in the interstitial collagen-- and fibronectin-rich matrix between tubules (in kidney) or myocytes (in heart). Second, each α chain is expressed in a unique pattern. Third, each BL contains at least one α chain. Fourth, BLs can contain either a single α chain (e.g., α5 in glomerular BL) or multiple α chains (e.g., α1 and α5 in proximal tubular BL or α3, α4, and α5 in some alveolar BLs). Fifth, even a single BL can vary in laminin composition along its length (e.g., α1 and α5 in proximal portions of tubular BL, α5 in distal portions, and α2 and α5 at the corticomedullary junction). Sixth, as surmised from studies at the RNA level (see above), α1 is most restricted in its expression, and α5 is the most broadly distributed in adult BLs. Together, these results support the idea that the functional diversity of BLs is achieved in part by laminin α chain diversity.

Finally, it is interesting to compare the distribution of the individual α chains to that previously documented for α1. Many studies, including some from our laboratory, have used the mAb 4C7 ([@B23]) to assess the distribution of α1 ([@B24]; [@B72]; [@B84], [@B85]; [@B74]; [@B19]). This antibody was shown to recognize a laminin α chain distinct from α2 at a time when only two α chains had been described ([@B24]), but since this antibody does not recognize mouse protein, it could not be tested on bona fide laminin α1 as originally isolated and cloned from the EHS tumor. 4C7-immunoreactive material is more broadly distributed than is α1-immunoreactive material, as recognized by mAbs that bind to mouse laminin α1 ([@B77]) and were used here. Interestingly, the array of BLs recognized by 4C7 most closely resembles that stained by anti-α5 in heart, lung, and kidney (Fig. [6](#F6){ref-type="fig"}), as well as in skeletal muscle (Patton, B.L., J.H. Miner, and J.R. Sanes, unpublished results). Unfortunately, direct comparisons are not feasible because 4C7 does not recognize mouse or rat antigen, and our antiα5 antiserum does not recognize rabbit or human antigen. However, we speculate that 4C7 may recognize the laminin α5 chain, either instead of or in addition to α1.

Developmental Transitions in Laminin α Chain Expression
-------------------------------------------------------

We next used our panel of antisera to ask when developing BLs acquire their complement of laminin α chains. Based on the studies of adult organs detailed above, and on the fact that laminins have been implicated as important in renal development and function ([@B48]; [@B61]), we focused on kidney for this analysis. In fact, we found a complex and dynamic pattern of laminin α chain expression in the BLs of the developing nephron. To document these results, it is first necessary to summarize the main stages of nephrogenesis (Fig. [7](#F7){ref-type="fig"}).

Nephrogenesis begins when the epithelial ureteric bud grows out of the mesonephric duct, invades loose metanephric mesenchyme, and induces it to condense into a sphere (Fig. [7](#F7){ref-type="fig"} *A*). The condensed mesenchyme then epithelializes, forming a vesicle, and secretes a BL around its periphery (Fig. [7](#F7){ref-type="fig"} *B*). One side of the vesicle and then the other invaginates to form, successively, a comma-shaped and an S-shaped figure (Fig. [7](#F7){ref-type="fig"}, *C* and *D*); during this process, a blood vessel invades the primary invagination. Next, the distal portion of the S-shaped body fuses with the ureteric bud to form the tubule, and the invading vessel branches within the widening invagination to form the rudimentary capillary loops of the glomerulus (Fig. [7](#F7){ref-type="fig"} *E*). Further ramification of the capillary loops and their enclosure by glomerular constriction lead successively to the immature and mature glomeruli (Fig. [7](#F7){ref-type="fig"}, *F* and *G*). Multiple waves of induction of cortical mesenchyme by the branching and lengthening ureteric bud make nephrogenesis a graded process that continues from E11 until postnatally, with newly forming nephrons just beneath the cortical surface and more mature stages at increasingly deep levels ([@B3]; [@B76]; [@B17]).

To search for potential developmental transitions in laminin α chain expression, we stained sections of E15.5 and neonatal mouse kidney with antibodies to laminins α1--5. Results are summarized in Fig. [7](#F7){ref-type="fig"} and examples are shown in Fig. [8](#F8){ref-type="fig"}. Before vesicle formation, the only BL near the cortical surface was that of the ureteric bud. This BL was rich in laminin α5 (Fig. [8](#F8){ref-type="fig"} *a*) throughout its length and also contained α1 (Fig. [8](#F8){ref-type="fig"} *g*) in the cortical portions. The first-formed BL of the nephron, that of the vesicle, contained laminins α1 (not shown) and α4 (Fig. [8](#F8){ref-type="fig"} *b*). Laminin α1 was detected in the BL of some but not all vesicles, suggesting that it appears after α4 near the end of the vesicle stage. In the comma, α1 and α4 remained (Fig. [8](#F8){ref-type="fig"}, *c* and *e*) and were joined by α5 (Fig. [8](#F8){ref-type="fig"} *a*). At this stage, significant heterogeneity became evident within the single BL that surrounded each comma: laminin α4 was present at higher levels in the tuft than in the periphery (Fig. [8](#F8){ref-type="fig"} *c*), whereas laminin α5 was clearly present in the periphery but was virtually absent from the tuft (Fig. [8](#F8){ref-type="fig"} *a*). Thus, the BL of the tuft, which is the precursor of the glomerular BL, becomes molecularly distinct from continuous but nonglomerular stretches of BL at an early stage of nephrogenesis.

At the S-shaped stage, distinct portions of the nephron that will give rise to the glomerular filtration apparatus, Bowman\'s capsule, and the tubule can be distinguished. Interestingly, BLs in each of these regions bore a different complement of laminin α chains. The progenitor of the glomerular BL was rich in α4 and α5 and contained low levels of α1; the progenitor of Bowman\'s capsule BL was rich in all three chains; and the progenitor of the tubular BL contained abundant α1, low levels of α5, and no detectable α4 (Fig. [8](#F8){ref-type="fig"}, *d* and *f*). In addition, the invading vessel, destined to generate the capillary loops of the glomerulus, was coated by a BL with yet a fourth composition: rich in α4 but with no detectable α1 or α5.

As summarized in Fig. [7](#F7){ref-type="fig"}, *E--G*, and documented in Fig. [8](#F8){ref-type="fig"}, *d*, *g*, and *h*, each stretch of BL underwent further changes in laminin α chain composition as the nephron matured. (*1*) In the BL of Bowman\'s capsule, α4 declined in level by the capillary loop stage and disappeared from the capsule in the immature glomerulus. Levels of α1 declined later, leaving the mature capsular BL rich in α5, poor in α1, and without detectable α4. (*2*) Tubular BL became richer in α5 as development proceeded. Different segments of the tubule either maintained or lost α1, or acquired α2, as described above (Fig. [6](#F6){ref-type="fig"}, *a--e*). (*3*) Arteriolar BL lost α4 and acquired α5 at a late stage of development. (*4*) The glomerular BL first lost α4 and then lost α1, leaving α5 as the only detectable laminin α chain in the adult. (*5*) Finally, the mesangial matrix was first detectable at the capillary loop stage, where it was α4 positive. Later, α4 disappeared from this matrix, and α1 and α2 accumulated.

It is interesting to compare the laminin α chain transitions in glomerular BL to those previously documented for the laminin β and collagen IV α chains (Abrahamson and St. John, 1993; [@B58]; [@B61]; [@B84]). Laminin β1 and collagen α1,2(IV) chains are present in the primitive comma and S-shaped figure BLs. At the capillary loop stage, they are joined by laminin β2 and collagen α3-5(IV) in the developing glomerular BL. At the immature glomerulus stage, laminin β1 and collagen α1,2(IV) levels begin to decline, leaving only laminin β2 and collagen α3-5(IV) in the mature glomerular BL. The later appearance of α5 and β2 raises the possibility that these two events are linked. However, the initial accumulation of laminin α5 occurs at the S-shaped stage, while laminin β2 and collagen α35(IV) do not appear until the capillary loop stage (Fig. [7](#F7){ref-type="fig"}, *D* and *E*). Likewise, the roughly parallel disappearance of laminins α1, α4, and β1 raises the possibility that this developmental step reflects loss of α1β1- or α4β1-containing trimers. However, laminin β1 was detectable in maturing glomerular BLs that lacked laminins α1 and α4 (data not shown), suggesting that elimination of these molecules is not obligatorily linked. Surprisingly, therefore, the developmental transitions in laminin α and β chains appear to be regulated independently. If all laminin chains occur in α/β/γ trimers (see below), these results suggest that α1β1-, α1β2-, α4β1-, α4β2-, α5β1-, and α5β2-containing trimers are potentially present, at least transiently, in developing glomerular BL.

To determine whether the isoform transitions detected at the protein level reflected regulation of gene expression, we performed in situ hybridizations on P1 kidney sections using probes for the α1--5 chains. As noted above, nephrons at all stages of development are present in a corticomedullary gradient in neonates, with the most primitive just beneath the cortical surface and the most mature at deeper levels. Laminin α4 transcripts were clustered at the cortex, as expected from its early appearance in vesicular BL (Fig. [9](#F9){ref-type="fig"} *d*). Laminin α1 transcripts were detected in cortical and subcortical clusters, consistent with the expression of this chain in late vesicle, comma, and S-shaped stages (Fig. [9](#F9){ref-type="fig"} *a*). Segments of tubules were also α1 positive, and lower level expression (above background) was found throughout the kidney. Low levels of laminin α5 RNA were present in the superficial layer of the cortex, consistent with the later appearance of this chain in the developing nephron. Occasional clusters that were observed are likely to be the tips of the ureteric buds that have BLs rich in α5 (Fig. [9](#F9){ref-type="fig"} *e*). Deep in the medulla, laminin α5 RNA was abundant in the collecting ducts, which are derived from the α5-positive ureteric bud. α5 labeling was not abundant in all structures that contained the protein (e.g., capillary loop stage glomeruli), suggesting that, in some cases, α5 RNA is unstable or simply present at low levels but translated efficiently. Laminin α2 RNA was concentrated in the deep cortical and medullary portions of the kidney (Fig. [9](#F9){ref-type="fig"} *b*), consistent with its localization in a subset of tubules (Fig. [6](#F6){ref-type="fig"} *b*). Laminin α3 RNA was not detectable within the renal cortex but was found at P15 in the papilla (data not shown), consistent with its protein localization in adult kidney (Fig. [6](#F6){ref-type="fig"} *c*).

Identification of Heterotrimers Containing the Laminin α4 or α5 Chain
---------------------------------------------------------------------

Current understanding of the structure and function of BLs is based on the assumption that all laminins are heterotrimers of α, β, and γ subunits, covalently joined by disulfide bonds ([@B9]). Such trimeric structures have been demonstrated for the α1--3 chains, which form laminins 1--7 (Table [I](#TI){ref-type="table"}), but not for α4 and α5. We therefore asked whether the α4 and α5 chains also occur as components of trimers. To this end, we fractionated proteins from lung and kidney on SDS gels under nonreducing conditions such that laminins migrate as trimers, the relative sizes of which depend on the constituent α, β, and γ chains. Nitrocellulose blots were then probed with antibodies to α4 or α5 (Fig. [10](#F10){ref-type="fig"} *A*). Both lung and kidney contained high *M* ~r~ complexes that reacted with the α4 (Fig. [10](#F10){ref-type="fig"} *A*, lanes *3* and *7*) or α5 (lanes *4* and *8*) antisera but not with nonimmune serum (lanes *2* and *6*). The α4 complexes were ∼500--600 kD, and the α5 complexes were ∼700--800 kD. These values are consistent with *M* ~r~s predicted for laminin trimers. None of the α4- or α5-immunoreactive bands (⩽450 kD) that had been seen after reduction (Fig. [5](#F5){ref-type="fig"} *B*) were detectable under these nonreducing conditions, indicating that all of the monomeric species were associated with larger, disulfide-bonded complexes. Moreover, the approximate difference in *M* ~r~ between the α4- and α5-containing complexes (∼200 kD) is consistent with the difference in *M* ~r~ between the full-length α4 and α5 chains themselves. An antiserum to laminin-1, which recognizes the α1, β1, and γ1 chains, blotted material at the *M* ~r~s of all α4- and α5containing complexes (Fig. [10](#F10){ref-type="fig"} *A*, lanes *1* and *5*), whereas anti-α4 and anti-α5 did not recognize laminin-1 (lanes *11* and *12*). Together, these results suggest that laminins α4 and α5 occur in heterotrimers with β1 and/or γ1 chains.

To definitively identify the α4- and α5-containing complexes as laminin heterotrimers, we solubilized and partially purified laminins from lung. Lung was chosen for this set of experiments because, unlike kidney, it expresses both α4 and α5 chains at high levels in adulthood (Figs. [3](#F3){ref-type="fig"} and [6](#F6){ref-type="fig"}). Lung homogenates were extracted with EDTA, EGTA, NaCl, and Triton X-100, and the extracts were then fractioned by a combination of ion exchange and size exclusion chromatography (see Materials and Methods). The resulting laminin-rich fraction was then subjected to immunoprecipitation with mAbs specific for laminin β1 or β2. Precipitates were separated on gels under nonreducing conditions, electroblotted onto nitrocellulose, and probed with antibodies specific for individual laminin chains (Fig. [10](#F10){ref-type="fig"} *B*). Antibodies to laminin β1 precipitated a series of complexes of ∼500--800 kD (Fig. [10](#F10){ref-type="fig"} *B*, lanes *1--5*). All the complexes comigrated with γ1 (Fig. [10](#F10){ref-type="fig"} *B*, lane *5*), but none contained β2 (lane *2*). Individual complexes reacted with either anti-α4 (Fig. [10](#F10){ref-type="fig"} *B*, lane *3*) or with anti-α5 (lane *4*) but not with both. Complexes containing α4 had *M* ~r~s of ∼500--600 kD, and those with α5 had *M* ~r~s of ∼700--800 kD, corresponding to *M* ~r~s of the nonreduced α4 and α5 complexes observed by immunoblotting crude lung samples (Fig. [10](#F10){ref-type="fig"} *A*). Controls in which the primary antibody was omitted did not contain laminins (Fig. [10](#F10){ref-type="fig"} *B*, lanes *14--18*). Thus, the laminin α4 and α5 chains are both associated with β1 in distinct heterotrimers.

Parallel results were obtained from material precipitated by antibodies to laminin β2 (Fig. [10](#F10){ref-type="fig"} *B*, lanes *6--10*). All of the laminin β2-reactive material precipitated by these antibodies (Fig. [10](#F10){ref-type="fig"} *B*, lane *7*) reacted with anti γ1 (lane *10*) and with either anti-α4 (lane *8*) or anti-α5 (lane *9*) but not both. Complexes containing α4 had *M* ~r~s of ∼500--600 kD, and those with α5 had *M* ~r~s of ∼700--800 kD, corresponding to those detected in crude lung samples (Fig. [10](#F10){ref-type="fig"} *A*). Electrophoresis of the immunoprecipitates under reducing conditions revealed that the major α4- and α5-reactive bands detected in crude extracts (Fig. [5](#F5){ref-type="fig"} *B*) were complexed with β2 (data not shown). Thus, lung also contains distinct laminin heterotrimers that include α4+β2 and α5+β2.

Two observations indicated that the complexes containing α4β1, α4β2, α5β1, and α5β2 also contained the γ1 chain. First, an mAb to γ1 precipitated α4- and α5-containing complexes (Fig. [10](#F10){ref-type="fig"} *B*, lanes *11--13*) that were equivalent in *M* ~r~ to those precipitated by anti-β1 or anti-β2. Second, as noted above, anti-β1 and anti-β2 precipitated γ1-containing complexes that comigrated with all of the α4- and α5immunoreactive trimers (Fig. [10](#F10){ref-type="fig"} *B*, lanes *5* and *10*). Together, these results provide strong evidence for the existence of laminin trimers with chain compositions of α4β1γ1, α4β2γ1, α5β1γ1, and α5β2γ1. In accordance with recently adopted rules of nomenclature ([@B9]), these are named laminins 8--11, respectively (Table [I](#TI){ref-type="table"}).

Chromosomal Mapping of Lama Genes
---------------------------------

The murine chromosomal locations of *Lama1--Lama5* were determined using an interspecific backcross mapping panel derived from crosses of \[(C57BL/6J × *M. spretus*) F1 X C57BL/6J\] mice. Mouse genomic or cDNA fragments specific for each locus were used as probes in Southern blot hybridization analysis of C57BL/6J and *M. spretus* genomic DNA that was separately digested with several different restriction enzymes to identify informative RFLPs (see Materials and Methods). The strain distribution pattern of each RFLP in the interspecific backcross was then determined by following the presence or absence of RFLPs specific for *M. spretus* in backcross mice.

Backcross mapping refined previously reported chromosomal locations for *Lama1--3* and provided the first data on mouse chromosomal locations of *Lama4* and *Lama5* (Fig. [11](#F11){ref-type="fig"}). *Lama1* has previously been reported to map to the distal region of mouse chromosome 17 in this interspecific backcross ([@B62]; [@B18]). *Lama2* mapped to the proximal region of mouse chromosome 10, 4.5 centiMorgans (cM) distal of *Myb* and 3.9 cM proximal of *Fyn.* This result is in good agreement with previous studies that map *Lama2* 3.2 ± 1.8 cM distal of *Myb* on mouse chromosome 10 ([@B78]). We have also confirmed the recent results of [@B2] and [@B34] by assigning *Lama3* to the proximal region of chromosome 18. In our interspecific cross, *Lama3* mapped 1.6 cM distal of *Tpl1* and 1.1 cM proximal of *Cdh2. Lama4* is linked to *Lama2* on chromosome 10 and does not recombine with *Fyn* in 129 animals typed in common, suggesting that the two loci are within 2.3 cM of each other (upper 95% confidence limit). Finally, *Lama5* mapped to the very distal region of mouse chromosome 2, 2.2 cM distal of *Gnas.* Thus, the five *Lama* loci were distributed on four different mouse autosomes, indicating that most of the *Lama* genes have become dispersed through evolution.

Previous studies have shown that the *Lama2* gene encodes the dystrophia muscularis (*dy*) mouse mutation ([@B78]; [@B88]), but no targeted or spontaneous mouse mutants have been reported for *lama1*, *3*, *4*, or *5.* Therefore, we compared our maps of mouse chromosomes 2, 10, 17, and 18 with composite mouse maps that report the map locations of many uncloned mouse mutations (obtained from the Mouse Genome Database, maintained at The Jackson Laboratory, Bar Harbor, ME). Mutations in the vicinity of the *Lama* genes include thin fur (*thf*) near the *Lama1* locus; ataxia (*ax*), twirler (*Tw*), and balding (*bal*) near the *Lama3* locus; waltzer (*v*) and kidney disease (*kd*) near the *Lama4* locus; and ragged (*Ra*) and wasted (*wst*) near the *Lama5* locus. For most of these mutations, the reported phenotypes are not suggestive of a BL defect. For ragged, however, the phenotype is an intriguing one. The mutation *Ra* shows semidominance, and the coats of heterozygotes have a thin ragged appearance. Homozygotes are naked, many die in utero, and there are internal visceral defects ([@B10]; [@B75]). Another semidominant allele of ragged, *Ra* \< *op* \> (opossum) ([@B32]), is homozygous lethal before E11, which, because of its expression in many tissues, might be expected for a *Lama5* mutant. Also, since α5 is expressed in the skin, a mutation may affect the function of hair follicles, which could lead to the ragged coat appearance. Moreover, the disruption of heterotrimeric laminin structure by a defective α chain could explain the semidominant phenotype of both ragged alleles identified to date.

Several of the *LAMA* genes have also been mapped to human chromosomes (summarized in Fig. [11](#F11){ref-type="fig"}). *LAMA1* maps to human 18p11.32-p11.22, *LAMA2* to 6q22-q23, *LAMA3* to 18q11.2, and *LAMA4* to 6q21. *LAMA1* is currently the only gene that maps to human chromosome 18 and mouse chromosome 17. Thus, *LAMA1* defines a new region of homology between mouse and human chromosomes. In contrast, the mouse and human map locations of *LAMA2--4* confirm and extend the known regions of homology between mouse and human chromosomes (Fig. [11](#F11){ref-type="fig"}; data not shown). *LAMA5* has not been mapped in humans. However, the distal region of mouse chromosome 2 shares a region of homology with human chromosome 20q13, suggesting that *LAMA5* will map to 20q13 in humans, as well. As noted in the Introduction, the *LAMA2* gene is mutated in some congenital muscular dystrophies, and the *LAMA3* gene is mutated in a subset of patients with a skin blistering disease, junctional epidermolysis bullosa. No human mutations that suggest a BL defect map to the vicinity of the human *LAMA1* or *LAMA4* locus or to the predicted *LAMA5* locus.

Conclusion
----------

The laminins are major components of BLs throughout the body, and their α chains are ligands for most cellular laminin receptors identified to date, including at least six integrins, dystroglycan, and several glycoconjugates (see Introduction). Yet the distribution of the laminin α chains has not previously been studied in detail, and the existence of the two most recently identified chains (α4 and α5) has been deduced from cDNA sequence but not shown directly at the protein level. We have therefore generated a panel of antibody and cDNA reagents and have used it to localize the α chain genes on mouse chromosomes and the α chain RNAs and proteins in developing and adult tissues. We have also identified a new isoform of laminin α3 and provided direct evidence for the existence of four novel laminin heterotrimers. Our main conclusions are as follows:

(*1*) The α subfamily of laminin genes currently consists of five members, which encode six proteins. Four (α1, α2, α3B, and α5) are full-sized chains, and two (α3A and α4) are truncated chains (Fig. [1](#F1){ref-type="fig"}). The previously hypothesized mid-sized α chain (α3B) may not, in fact, exist (Fig. [2](#F2){ref-type="fig"}).

(*2*) All five of the laminin α chain genes are expressed in both embryos and adults, but each is expressed in a distinct pattern (Figs. [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). Their products are confined to the extracellular matrix and, with a few exceptions (e.g., the glomerular mesangium), to BLs (Fig. [6](#F6){ref-type="fig"}).

(*3*) All developing and adult BLs studied to date contain at least one of the known α chains, and some contain two or three distinct α chains. Although additional α chains may well exist, our results provide no evidence for them and no clues as to their nature or distribution.

(*4*) Laminin α5 is the most widely distributed α chain in adult BLs, and α1 is the most restricted. The α2 chain is particularly abundant in mesodermally derived tissues (e.g., skeletal and cardiac muscle), and α3 is concentrated in epithelial BLs. The restricted distribution of α1 is inconsistent with the broad distribution of immunoreactive material recognized by a widely used mAb, 4C7. This discrepancy, together with data on the distribution of α2--5, raises the possibility that 4C7 recognizes the α5 chain, in addition to or instead of α1.

(*5*) The main patterns of α chain expression are established embryonically (Fig. [4](#F4){ref-type="fig"}), but some individual BLs change in α chain composition as development proceeds. In kidney, for example, forming glomeruli express three different α chains in a dynamic progression. Moreover, distinct portions of a continuous BL, such as that of the nephron, can contain distinct complements of α chains, and these change during development as well (Figs. [7](#F7){ref-type="fig"} and [8](#F8){ref-type="fig"}).

(*6*) Laminins α1--5 all form heterotrimers with β and γ chains. At present, 11 distinct heterotrimers have been identified in mammalian cells or tissues, including at least two containing each α chain (Table [I](#TI){ref-type="table"}). The four heterotrimers identified in this study (Fig. [10](#F10){ref-type="fig"}) have been named laminins-8 (α4β1γ1), -9 (α4β2γ1), -10 (α5β1γ1), and -11 (α5β2γ1).

(*7*) The five α chain genes are distributed on four chromosomes in mouse, and probably on three chromosomes in human. The two α chain genes present on a single chromosome in both species (α2 and α4) are not tightly linked, and two chains present on the same chromosome in humans (α1 and α3) are on different chromosomes in mouse (Fig. [11](#F11){ref-type="fig"}). Thus, there is no evidence for functionally important linkage of the α chain genes.

The patterns of expression that we have documented indicate that the α chains contribute importantly to the molecular diversity of BLs. Together with evidence that some cellular receptors can distinguish among α chains and that naturally occurring mutations of α2 and α3 have tissuespecific phenotypes (see Introduction), our results suggest that differences among α chains are critical to the multiplicity of roles that BLs play both during development and in maturity.

Note Added in Proof:
====================

A third α3 transcript with a distinct 5′ end and translation start site has now been identified by D. Aberdam and colleagues. It encodes a protein intermediate in size between the α3B isoform reported here and the α3A isoform described by [@B27]. Thus, there may be three isoforms of laminin α3: short (A), fulllength (B), and mid-sized (C) (Aberdam, D., personal communication).
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![The laminin α chain subfamily. Numbering of domains is based on accepted nomenclature ([@B73]; [@B22]). Numbers of laminin-type cysteine-rich (EGFlike) repeats, rounded to the nearest integer, are indicated within each domain IIIa, IIIb, or V. Note that laminins α3A and α3B share domains G, I/II, and IIIa but have distinct NH~2~ termini.](JCB.miner1){#F1}

![Nucleotide and deduced amino acid sequences of the laminin α3B chain, 5′ and NH~2~-terminal to those reported by [@B27]. Overlapping nucleotides are in lowercase. The Galliano sequence contains a single deoxyguanosine (*parentheses*) not found in our sequence, which shifts the reading frame and leads to an encoded methionine (*bottom line*, *italics*). Domains are marked as in Fig. [1](#F1){ref-type="fig"}. This was hypothesized to be the initiator for translation. An adhesive tripeptide sequence, LRE ([@B40]), is indicated by bullets; another LRE is located in the G domain ([@B27]). These sequence data are available from GenBank under accession number U88353.](JCB.miner2){#F2}

![Ribonuclease protection analysis of laminin α chain expression in (*A*) adult and (*B*) E17.5 mouse tissues. A probe for elongation factor 1α was used to control for the amount of input RNA in both embryos (*B*) and adults (not shown). Each α chain is expressed in a distinct pattern in the adult and, in general, these patterns are established by birth. The α5 chain is the most highly expressed, and α1 is the most restricted. *B*, brain; *I*, intestine; *H*, heart; *K*, kidney; *Li*, liver; *Lu*, lung; *M*, skeletal muscle; *S*, skin; *P*, placenta; *Y*, yeast RNA. The sample of E17.5 placental RNA was included in the panel of adult RNAs to allow comparison between experiments. *nd*, not done.](JCB.miner3){#F3}

![In situ hybridization of laminin α chain probes to E15.5 embryo parasagittal sections. (*a*) α1, (*b*) α2, (*c*) α3, (*d*) α4, and (*e*) α5. α1 shows restricted expression in kidney and meninges (*arrowheads*); α2 and α4 show widespread expression in mesenchymal cells and derivatives as well as in dorsal root ganglia (*arrowheads*); and α3 and α5 transcripts localize primarily to epithelia. (*f--h*) High power views of (*f*) α3, (*g*) α4, and (*h*) α5 expression in lung. α3 and α5 are concentrated in the epithelial lung buds, and α4 to the mesenchyme. *H*, heart; *K*, kidney; *L*, lung; *SG*, salivary gland; *T*, tongue (muscle). Bars: (*d*) 1 mm; (*h*) 50 μm.](JCB.miner4){#F4}

![Identification of laminin α4 and α5 proteins in lung and kidney. (*A*) Characterization of antisera. The α4 and α5 fusion proteins used to immunize rabbits were fractionated by SDSPAGE on 12% gels and transferred to blots. Strips were probed either with no primary antibody (lanes *1* and *4*), with the anti-α4 antiserum (lanes *2* and *5*), or with the anti-α5 antiserum (lanes *3* and *6*). Each antiserum specifically recognized its cognate immunogen. (*B*) Solubilized and reduced crude membranes from adult rat lung and kidney and purified laminin-1 were fractionated on 7% gels and transferred to blots. Strips were probed either with anti--laminin-1 (lanes *1*, *6*, and *10*), nonimmune (lanes *2*, *7*, and *11*), antilaminin α4 (lanes *3*, *8*, and *12*), or anti-laminin α5 (lanes *4*, *5*, *9*, and *13*). The anti-α4 serum recognized a protein of ∼180 kD in lung and kidney. The α5 antiserum recognized several bands in lung and kidney (lanes *4* and *9*), the largest of which, ∼450 kD, was observed only after long exposures (lane *5*, *arrowheads*). Neither serum recognized laminin α1 (lanes *12* and *13*). *n.i.*, nonimmune serum; *x*, nonspecific bands seen in all lung lanes with long exposures.](JCB.miner5){#F5}

![Immunohistochemical localization of laminin α chains in adult mouse kidney (*a--e*), heart (*f--j*), and lung (*k--o*). All five α chains were present in adult BLs, but each chain was distributed in a distinct pattern. α1 was found only in kidney mesangium and in a subset of tubular BLs (primarily proximal) (*a*). α2 was present in mesangium (*b*), in a subset of corticomedullary tubular BLs (*b*, *inset*), and in cardiomyocyte BLs (*g*). α3 was detected in kidney papillary BL (*c*) and in lung alveolar BL (*m*). α4 was absent from renal cortex (*d*) but found in capillaries of both the renal medulla (not shown) and heart (*i*), and in alveolar BLs in lung (*n*). α5 showed the most widespread expression: in all kidney BLs---glomerular, tubular, and arterial (*e*); in heart blood vessels and in some cardiomyocyte BLs (*j*); and in lung alveolar BL (*o*). *G*, glomerulus; *M*, mesangium; *bv*, blood vessel. Bar, 50 μm.](JCB.miner6){#F6}

![Schematic summary of kidney development, and expression patterns of the laminin α chains in various nephron segment BLs. The laminin α and β chains expressed in the developing glomerular BL (*GBM*) and its progenitors are boxed. See text for details.](JCB.miner7){#F7}

![Immunohistochemical analysis of laminins α1, α4, α5, and γ1 in developing kidney shows the dynamic pattern of α chain accumulation depicted schematically in Fig. [7](#F7){ref-type="fig"}. All sections are from P1 mouse kidney except *c*, which is from E15.5. *b*′, *c*, *d*′, *f*′, *g*, and *h*′ are double exposures of doubly labeled sections; antibodies listed first and second are shown in green and red, respectively, and regions of overlap are indicated by yellow and light orange. Single exposure companions are shown in *b* (for *b*′), *d* (for *d*′), *f* (for *f*′), and *h* (for *h*′). *U*, ureteric bud; *V*, vesicle; *C*, comma-shaped structure; *S*, S-shaped structure; *CL*, capillary loop; *mG*, maturing glomerulus; *bv*, blood vessel. (*Arrows*) Progenitors of glomerular BL. Bar, 50 μm.](JCB.miner8){#F8}

![In situ hybridization of laminin α chain probes to P1 kidney sections. α1 was observed in primitive structures in the cortex and in some tubules (*a*). α2 was absent from the cortical structures but distributed diffusely in the interior (*b*). α4 was detected primarily in clusters at the cortex (vesicle and comma stage nephrons) but also diffusely in the medulla (*d*). α5 was mainly in the collecting ducts, but there were also grain clusters in the inner cortex and in the medulla (*e*). α3 was absent (*c*), and a sense control was negative (*f*). These patterns suggest that the developmental transitions demonstrated immunohistochemically in Figs. [7](#F7){ref-type="fig"} and [8](#F8){ref-type="fig"} reflect, in part, developmental transitions in α chain gene expression. The cortical surface of the kidney is outlined in white. Insets in *a--e* show higher power views of the cortex. Bars: (*f*) 0.5 mm; (*a*, *inset*) 0.1 mm.](JCB.miner9){#F9}

###### 

Composition of Laminin Trimers

  Trimer          Components                                      References
  ------------ -- -------------------------------------------- -- ------------
  Laminin-1       α1β1γ1                                          [@B8]
  Laminin-2       α2β1γ1                                          [@B24]
  Laminin-3        αlβ2γ1[\*](#TFI-150){ref-type="table-fn"}      [@B24]
  Laminin-4       α2β2γ1                                          [@B24]
  Laminin-5       α3β3γ2                                          [@B69]
  Laminin-6       α3β1γ1                                          [@B53]
  Laminin-7       α3β2γ1                                          [@B12]
  Laminin-8       α4β1γ1                                          This study
  Laminin-9       α4β2γ1                                          This study
  Laminin-10      α5β1γ1                                          This study
  Laminin-11      α5β2γ1                                          This study

α1 identified immunochemically with the 4C7 mAb.  

![Biochemical identification of laminins-8, -9, -10, and -11. (*A*) Detection of laminin complexes containing α4 and α5. Crude membrane preparations from adult lung and kidney and purified laminin-1 were solubilized without reducing agent and fractionated by SDS-PAGE on 3.5% polyacrylamide gels. Proteins were transferred to nitrocellulose and probed with nonimmune (*n.i.*) serum (lanes *2*, *6*, and *10*) or with antibodies to laminin-1 (lanes *1*, *5*, and *9*), α4 (lanes *3*, *7*, and *11*), or α5 (lanes *4*, *8*, and *12*). The size of the laminin-1 trimer (∼800 kD) is indicated. Lung contained at least two complexes containing α4 (lane *3*), while kidney contained multiple α5-positive complexes (lane *8*). Laminin-1 contained little or no detectable α4 or α5. (*B*) Identification of laminin trimers from adult lung. Laminins were solubilized, partially purified, and then immunoprecipitated with antibodies to laminin β1 (lanes *1--5*), β2 (lanes *6--10*), γ1 (lanes *11--13*), or without primary antibody (lanes *14--18*). The precipitates were then fractionated on nonreducing gels and probed without primary antibody (lanes *1*, *6*, *11*, and *14*), or with antibodies to laminins β2 (lanes *2*, *7*, and *15*), α4 (lanes *3*, *8*, *12*, and *16*), α5 (lanes *4*, *9*, *13*, and *17*), and γ1 (lanes *5*, *10*, and *18*). Four novel laminin trimers were identified: laminin-8 (α4β1γ1), laminin-9 (α4β2γ1), laminin-10 (α5β1γ1), and laminin-11 (α5β2γ1).](JCB.miner10){#F10}

![Chromosomal locations of *Lama* loci in the mouse genome, as determined from interspecific backcross analysis. The number of recombinant N~2~ animals is presented over the total number of N~2~ animals typed to the left of the chromosome maps between each pair of loci. The recombination frequencies, expressed as genetic distance in centimorgans (± one standard error) are also shown. The upper 95% confidence limit of the recombination distance is given in parentheses when no recombinants were found between loci. Gene order was determined by minimizing the number of recombination events required to explain the allele distribution patterns. The positions of loci on human chromosomes, where known, are shown to the right of the chromosome maps. (*Asterisk*) The human *LAMA5* gene is predicted to reside on chromosome 20q13. References for the human map positions of loci cited in this study can be obtained from GDB (Genome Data Base), a computerized database of human linkage information maintained by The William H. Welch Medical Library of The Johns Hopkins University (Baltimore, MD).](JCB.miner11){#F11}
